Nephros Receives FDA 510(k) Clearance of HydraGuard(TM) 10″ UltraFilter

Expands Hospital Infection Control Product Line RIVER EDGE, NJ NEPH, (Marketwired Dec 27, 2016) Nephros, Inc. (OTCQB: NEPH) (the Company ), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ( HDF ) system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ( FDA ) to market its HydraGuard™ 10 UltraFilter.
http://bit.ly/2iAONHR